BioBeats

BioBeats was a pioneering London-based HealthTech company that specialized in leveraging artificial intelligence and biometric data to monitor and manage stress. Founded in 2012, the company developed a sophisticated platform that integrated with wearable devices to provide personalized insights into mental health and wellbeing. By utilizing machine learning, BioBeats aimed to shift the paradigm of mental healthcare from reactive treatment to proactive, evidence-based prevention, particularly within corporate environments. In April 2020, the company was acquired by the digital health firm Huma, marking a significant milestone in its mission to scale its technology for broader clinical and enterprise applications. The company's work was deeply rooted in scientific research, with its founders focusing on the intersection of neuroscience, psychology, and data science to address the global burden of stress-related illnesses.

The mission of BioBeats was to free all people of mental health suffering and to disrupt how stress is viewed and treated globally by replacing reactive mental healthcare with a proactive, evidence-based approach using AI and big data.

• Acquired by Huma in April 2020
• Raised approximately $6–7 million in venture capital funding
• Conducted clinical trials and pilots with major organizations including BUPA, AXA, and the NHS
• Published research on workplace stress in peer-reviewed journals such as Frontiers in Human Neuroscience
• Recipient of InnovateUK awards for clinical excellence and adaptive media innovation

Sources

• Official BioBeats Website
• Huma Official Website (Acquirer)
• Crunchbase Profile